Amplification of anticancer efficacy by co-delivery of doxorubicin and lonidamine with extracellular vesicles

Chemotherapy is commonly used for the treatment of lung cancer, but strong side effects and low treatment efficacy limit its clinical application. Here, extracellular vesicles (EVs) as natural drug delivery carriers were used to load conventional anticancer drug doxorubicin (DOX) and a chemosensitiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huizhen, Xu, Wan, Li, Fang, Zeng, Ru, Zhang, Xiuming, Wang, Xianwu, Zhao, Shaojun, Weng, Jian, Li, Zhu, Sun, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741238/
https://www.ncbi.nlm.nih.gov/pubmed/34984953
http://dx.doi.org/10.1080/10717544.2021.2023697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741238/
https://www.ncbi.nlm.nih.gov/pubmed/34984953
http://dx.doi.org/10.1080/10717544.2021.2023697

Ejemplares similares